Clinical study on the efficacy and safety of ganghuokanggan granule in the treatment of dengue fever

Clinical study of ganghuokanggan Decoction on dengue fever

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2100004502

Enrollment

Unknown

Registered

2021-02-28

Start date

2021-04-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dengue fever

Interventions

two:Ganghuo Kanggan granule simulator

one:Ganghuo Kanggan granules

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Those who meet the diagnostic criteria of dengue fever in acute fever stage of Western medicine. (2) It is in accordance with the syndrome differentiation and diagnosis standard of heat dampness depression and Wei Qi disease. (3) The age ranged from 18 to 65 years (including 18 and 65 years). (4) The onset time was less than 5 days, without TCM treatment. (5) According to GCP, informed consent was obtained and volunteers were enrolled.

Exclusion criteria

Exclusion criteria: The clinical diagnostic criteria of dengue fever were not met

Design outcomes

Primary

Measure	Time frame
Time of complete fever reduction after treatment;Conversion rate of severe dengue fever;	—

Secondary

Measure	Time frame
TCM syndrome;TCM syndrome;Clinical symptoms of dengue fever;Serum dengue virus load;Routine laboratory indicators;	—

Countries

china

Contacts

Public Contactliu xiaohong

The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine

rsclxh@gzucm.edu.cn+86 13926002208

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026